Gujarat Themis Biosyn, an India-based pharma firm, has announced a 1:5 stock split and a dividend of Rs 1 for the financial year ended March 2023. The company plans to subdivide one equity share of face value of Rs. 5 into five parted equity shares worth Rs. 1 each. Shareholders who hold the stock until the record date will receive the new shares in their demat accounts. The company’s stock price has tripled in the last two years, generating attractive returns for investors.
